Every extra 10 µg/m³ of particle pollution tracked with 15.1% more heart deaths

Fine particulate matter, the microscopic pollution known as PM2.5, reaches deep into the lungs and has long been linked to heart and lung disease. Much of the foundational evidence came from North America and Europe, where pollution levels and populations differ substantially from China's. During China's 13th Five-Year Plan period the country produced a wave of new epidemiological research, and this review set out to pull it together into exposure-response relationships specific to China. Those relationships matter because they underpin air quality standards and the policies that follow from them.

The authors searched PubMed, Web of Science and two major Chinese databases for original studies published between 1 January 2016 and 30 June 2021 on PM2.5 and cardiorespiratory outcomes in China. From 8558 records identified, 145 met the full eligibility criteria. Effect estimates were pooled statistically where appropriate, covering both short-term exposure, meaning day-to-day swings in pollution, and long-term exposure over years. Outcomes ranged from deaths and new diagnoses to blood pressure, lung function and markers of inflammation.

Each 10 µg/m³ rise in short-term PM2.5 exposure was associated with increases of 0.70% in cardiovascular mortality, 0.86% in respiratory mortality, 0.38% in cardiovascular morbidity and 0.96% in respiratory morbidity. The long-term picture was starker: per 10 µg/m³, cardiovascular mortality rose 15.1%, stroke mortality 11.9% and lung cancer mortality 21.0%, while new cases of cardiovascular disease, hypertension and lung cancer rose 17.4%, 11.0% and 4.88% respectively. Significant associations covered stroke, ischaemic heart disease, heart failure, arrhythmia, chronic obstructive pulmonary disease, pneumonia and allergic rhinitis. Adverse changes also appeared in blood pressure, heart rate variability, systemic inflammation, blood lipids, lung function and airway inflammation.

The short-term associations were generally smaller in magnitude than those reported in developed countries, while the long-term associations were comparable. That pattern refines a literature previously dominated by Western populations and gives Chinese regulators exposure-response curves grounded in their own data. As with all research that follows people rather than experimenting on them, these estimates describe associations rather than proven causation. The authors note that meaningful gaps remain and merit further investigation in China.

Air quality is one of the few health exposures you cannot fully opt out of, and this review is a reminder that its footprint shows up across the heart and the lungs, in deaths, new diagnoses and subtler measures like blood pressure. The dose-response framing is the part worth absorbing: risk climbed with each additional increment of pollution, and long-term exposure carried the larger associations. That is a reason to pay attention to sustained air quality where you live, not just the occasional smoggy day.